Oct. 7 (UPI) — Around the world, nitrous oxide emissions are rising, imperiling the effort to meet the climate goals set by the Paris Agreement.
According to a new study, published Wednesday in the journal Nature, the growing use of nitrogen fertilizers by industrial agriculture has led to a dramatic increase in N2O emissions.
For the study, researchers analyzed major N2O sources and sinks all over the world. The effort was aided by scientists from 48 research institutions in 14 countries.
“This study presents the most comprehensive and detailed picture to date, of N2O emissions and their impact on climate,” lead study author Parvadha Suntharalingam, climate scientist at the University of East Anglia in Britain, said in a news release.
The data showed modern atmospheric nitrous oxide levels are 20 percent higher than preindustrial levels, increasing to 331 parts per billion in 2018 from 270 parts per billion in 1750.
New multi-year MLSA provides launch capacity for nine microsats, end-to-end mission management services, and schedule reliability for fast-growing radio signal mapping constellation
Spaceflight Inc., the leading satellite rideshare and mission management provider, today announced it signed a Multiple Launch Services Agreement (MLSA) with HawkEye 360. Under the agreement, Spaceflight will provide capacity, engineering, and mission management services to launch HawkEye 360’s Cluster 4, 5, and 6 of its radio frequency mapping satellites. Each cluster in the constellation consists of three approximately 30 kg microsats which fly in a unique formation to gather a wide variety of geolocation data.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201007005256/en/
Spaceflight Inc. signs multi-year MLSA with HawkEye 360 to provide launch capacity for nine microsats, end-to-end mission management services, and schedule reliability for fast-growing radio signal mapping constellation (Photo: Business Wire)
HawkEye 360 first worked with Spaceflight in 2018, successfully launching
Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exclusive royalty-bearing license agreement with Abbott Laboratories (NYSE: ABT), the global healthcare company. The non-exclusive license grants Abbott access to Quanterix’ portfolio of bead-based technology patents for use in in vitro diagnostic (IVD) applications.
Under the terms of the agreement, Quanterix will receive an initial license fee, milestone fees subject to the achievement by Abbott of future development, regulatory, and launch milestones and royalties on the sale of licensed products. To learn more about Quanterix, click here.
Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from
CAESAREA, Israel, Oct. 5, 2020 /PRNewswire/ — IceCure Medical Ltd. (TASE: ICCM), developer of the next generation cryoablation technology that destroys tumors by freezing without the need for surgery, today announced that it has expanded its strategic partnership with Terumo Corporation (Tokyo: 4543) (TRUMY: OTC US), a leading Japanese medical devices company with a global footprint. The expanded partnership reflects the ongoing success of the initial agreement, which was signed in September 2019, and included distribution rights in Japan and Singapore.The new multi-million dollar agreement, which is expected to be finalized by the end of the year, will grant Terumo exclusive rights to distribute IceCure’s products in Thailand for six years, with an option to extend the agreement for an additional six years.
Under the terms of a Letter of Intent (LOI), in exchange for granting exclusive distribution rights and knowledge-sharing for ProSense™ and
Genuity Science’s approach combines high-quality, whole-genome sequence and deep phenotype data resulting in better definition of the underlying disease mechanisms. This approach, when coupled with Ionis’ proprietary antisense technology, has the potential to significantly expedite the drug development process through a more direct translation of targets into therapeutics.
Under terms of the multi-year collaboration, Genuity Science will receive a combination of upfront payments and development milestones, plus product royalties.
“Ionis’ financial strength and the success of our validated antisense technology have positioned us to invest in new technologies that enhance our R&D capabilities,” said Brett P. Monia, Ph.D., chief executive officer of Ionis. “The collaboration with Genuity Science gives us the potential to significantly increase our discovery opportunities and better understand the complexities of human diseases based on genetics.”
“We are excited to collaborate with an innovative company like Ionis,” said Rob Brainin, chief executive officer of Genuity
RIVIERA BEACH, Fla., Oct. 1, 2020 /PRNewswire/ —Transform Materials, a sustainable chemical company that uses microwave plasma technology to convert natural gas into acetylene and hydrogen, has signed a global licensing agreement with DSM Nutritional Products Ltd. Under this agreement, DSM will use the patented Transform technology to produce certain vitamins, carotenoids, and nutritional ingredients, with Transform providing technical support to ensure success of the integration.
Transform has developed a highly selective, cost-effective, net-carbon-negative process that converts the methane in natural gas into high-value products suitable for direct use or downstream reactions.
“We transform methane into acetylene and hydrogen, critical precursors for the synthesis of high-value chemical end products, without using traditional techniques that form carbon dioxide. That means we can meet important future needs of the chemical industry without creating harmful greenhouse gases,” said David Soane Ph.D., CEO of Transform Materials. “An important benefit of our technology
BEIJING, Sept. 30, 2020 /PRNewswire/ — AirNet Technology Inc., formerly known as AirMedia Group Inc. (“AirNet” or the “Company”) (Nasdaq: ANTE), an in-flight solution provider on connectivity, entertainment, and digital multimedia in China, today announced that it has entered into an equity purchase framework agreement (the “Agreement”) with BitGeek Information Technology Co., Ltd. (“BitGeek”) and BitGeek’s shareholders, independent third parties of the Company, to purchase 100% of the equity interests in BitGeek with an issuance of ordinary shares of the Company to BitGeek’s shareholders. Details pertaining to the purchase will be further discussed and stipulated in a binding agreement among the parties after completion of the valuation of BitGeek.
Mr. Herman Guo, the Chairman and CEO of the Company, commented “The acquisition of the equity interest in BitGeek will align the Company with the swift advancements of the blockchain technology as well as equipment specifically designed
YANTAI, China, Sept. 29, 2020 /PRNewswire/ — Newater Technology, Inc. (NASDAQ: NEWA) (“NEWA“, or the “Company“), a developer, service provider and manufacturer of membrane filtration products and related hardware and engineered systems that are used in the treatment, recycling and discharge of wastewater, today announced that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement“) with Crouching Tiger Holding Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“Parent“), and Green Forest Holding Limited, a company with limited liability incorporated under the laws of the British Virgin Islands and a wholly-owned subsidiary of Parent (“Merger Sub“), pursuant to which Parent will acquire the Company for US$3.65 per common share of the Company.
Subject to the terms and conditions of the Merger Agreement, at the effective time of the
WASHINGTON — Italy is the latest country to sign an agreement to cooperate with NASA on the Artemis human lunar exploration program, although the details of Italy’s participation have yet to be worked out.
In a Sept. 25 ceremony held by videoconference, NASA Administrator Jim Bridenstine and Riccardo Fraccaro, undersecretary to Italian Prime Minister Giuseppe Conte with responsibility for space, signed a joint declaration of intent to cooperate on Artemis.
“With a long history of successful collaboration in human spaceflight, as well as in Earth and space science, the Italian government’s strong support for Artemis assures this partnership will extend to cooperation in the next phase of exploration on the lunar surface,” Bridenstine said in a statement.
Neither NASA nor the Italian space agency ASI announced any specific projects that are part of that cooperative effort. In an Italian-language statement, Giorgio Saccoccia, president of ASI, said subsequent “implementation agreements” would
The U.S. and the U.K. formally committed to the Declaration on Cooperation in Artificial Intelligence Research and Development, which is meant to promote cooperation between the two nations on AI development along with recommending priorities for AI planning and programming, including student and researcher collaboration.
According to the White House’s Office of Science and Technology Policy (OSTP), the agreement is the result of a meeting between President Trump and British Prime Minister Boris Johnson last year, during which a U.S.-U.K. Special Relationship Economic Working Group was established to promote collaboration on economic growth.
“America and our allies must lead the world in shaping the development of cutting edge AI technologies and protecting